对慢性病中认知障碍背后的机制的新见解
Mickaël Bobot1, Stéphane Burtey2
1Centre de Néphrologie et Transplantation Rénale, Hôpital de la Conception, Assistance Publique - Hôpitaux de Marseille, Marseille, France; Aix Marseille Univ, INSERM 1263, INRAE 1260, Centre de Recherche en CardioVasculaire et Nutrition, Marseille, France; Centre Européen de Recherche en Imagerie Médicale, Aix-Marseille University, Marseille, France.
Kidney international
|November 22, 2024
概括
慢性病 (CKD) 通过影响血脑屏障,增加认知障碍的风险. 流和微质中的相关通路是关键因素,为CKD相关的大脑问题提供了新的治疗点.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 神经学 神经学
- 免疫学 免疫学 免疫学
背景情况:
- 慢性病 (CKD) 是认知障碍的重要危险因素.
- 在CKD患者中观察到血脑屏障 (BBB) 透性增加,可能导致神经系统缺陷.
研究的目的:
- 阐明CKD认知障碍背后的病理生理机制.
- 确定潜在的治疗目标,以减轻与CKD相关的认知功能障碍.
主要方法:
- 这项研究研究了流在微质激活中的作用.
- 它检查了介质素-1b/介质素-1R通路在BBB透性和认知变化中的参与.
- 尿路毒性被认为是导致因素.
主要成果:
- 微质中的流导致它们的激活.
- 激活的微质细胞和介质素-1b/介质素-1R通路与增加的BBB透性有关.
- 这些机制在CKD的背景下有助于认知障碍.
结论:
- 通过流和IL-1b/IL-1R通路的微质激活在CKD相关的BBB功能障碍和认知障碍中至关重要.
- 这些发现为CKD认知衰退的病理生理学提供了新的见解.
- 已识别的途径代表了管理慢性病患者认知缺陷的潜在治疗点.
相关概念视频
Factors Affecting Renal Clearance: Renal Impairment
54
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
54
Alzheimer's Disease: Overview
448
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
448
Nephrons
2.2K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
2.2K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
98
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
98
Renal Failure: Dose Adjustments
64
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
64
Cognitive Development During Adulthood
55
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
55


